Precision BioSciences, Inc. (DTIL)
NASDAQ: DTIL · Real-Time Price · USD
7.36
-0.51 (-6.48%)
At close: Jul 20, 2026, 4:00 PM EDT
7.42
+0.06 (0.78%)
After-hours: Jul 20, 2026, 6:43 PM EDT
Precision BioSciences Market Cap
Precision BioSciences has a market cap or net worth of $189.9 million as of July 20, 2026. Its market cap has increased by 271.51% in one year.
Market Cap
189.90M
Enterprise Value
120.67M
1-Year Change
271.51%
Ranking
Category
Stock Price
$7.36
ChartMarket Cap Chart
Since March 28, 2019, Precision BioSciences's market cap has decreased from $855.07M to $189.90M, a decrease of -77.79%. That is a compound annual growth rate of -18.59%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 189.90M | 89.64% |
| Dec 31, 2025 | 100.14M | 242.63% |
| Dec 31, 2024 | 29.23M | -34.32% |
| Dec 29, 2023 | 44.50M | -66.30% |
| Dec 30, 2022 | 132.04M | -70.64% |
| Dec 31, 2021 | 449.68M | 2.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 28, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Keros Therapeutics | 210.59M |
| Whitehawk Therapeutics | 209.22M |
| Agenus | 208.63M |
| Atrium Therapeutics | 207.83M |
| Immunic | 206.50M |
| NovaBridge Biosciences | 205.85M |
| Codexis | 203.61M |
| Minerva Neurosciences | 198.93M |